BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Heska Corporation (HSKA) Announces Amendment to Its Odd-Lot Tender Offer


10/10/2012 9:43:29 AM

LOVELAND, Colo., Oct. 9, 2012 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today that it has filed with the Securities and Exchange Commission ("SEC") an amendment to its offer to purchase. As described in its offer to purchase, the Company is offering $9.50 for each share of its common stock held by stockholders who owned, of record or beneficially, 99 or fewer shares as of the close of business on August 21, 2012, and who continue to hold such shares through the expiration of the offer.

Investors may obtain copies of the Company's Schedule TO filed August 27, 2012, the amendment filed on September 14, 2012, the amendment filed on Schedule 13E-3 on September 25, 2012, and the amendment filed today from the SEC at no charge by visiting the SEC's website (www.sec.gov). With today's amendment, the Company filed an Amended Offer to Purchase, Amended Letter of Transmittal, and Amended Notice of Guaranteed Delivery, which reflect all amendments made to date. The Company will make copies available to interested stockholders upon request. Company stockholders with questions or requests for documents, including a copy of the Amended Offer to Purchase, Amended Letter of Transmittal, and Amended Notice of Guaranteed Delivery, may call the Company's information agent in this matter, Morrow & Co., LLC, at (800) 607-0088.

The following details the changes made to the offer to purchase. Except as otherwise noted below, no changes have been made to the Schedule 13E-3 filed by the Company on September 25, 2012.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES